Literature DB >> 23689662

Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

Ravindra L Mehta1, Hamid Rabb, Andrew D Shaw, Kai Singbartl, Claudio Ronco, Peter A McCullough, John A Kellum.   

Abstract

Cardiorenal syndrome type 5 (CRS-5) includes conditions where there is a simultaneous involvement of the heart and kidney from a systemic disorder. Given the wide spectrum of diseases that contribute to CRS-5, several pathophysiological mechanisms are invoked representing the response of the heart and kidney to the contributing disorder that is ongoing. The nature, duration and the underlying condition of the heart and kidney strongly influence the clinical course of CRS-5. In this paper we discuss the pathophysiology of CRS-5 in the setting of sepsis as a model system for CRS-5 providing a brief overview of strategies for monitoring and therapeutic intervention. We offer a framework for reference for considering other disorders leading to CRS-5 where the development of cardiac and renal dysfunction is more insidious.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23689662     DOI: 10.1159/000349970

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  14 in total

1.  Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography.

Authors:  Thomas A Mavrakanas; Aisha Khattak; Karandeep Singh; David M Charytan
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-11       Impact factor: 8.237

Review 2.  Changes in renal function in congestive heart failure.

Authors:  Guido Boerrigter; Berthold Hocher; Harald Lapp
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 3.  Cellular apoptosis in the cardiorenal axis.

Authors:  Grazia Maria Virzì; Anna Clementi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

Review 4.  The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5.

Authors:  Anna Clementi; Grazia Maria Virzì; Alessandra Brocca; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2017-06-24       Impact factor: 2.041

Review 5.  Cardiohepatic syndrome: liver injury in decompensated heart failure.

Authors:  Said Laribi; Alexandre Mebazaa
Journal:  Curr Heart Fail Rep       Date:  2014-09

6.  Gadolinium-based contrast media exposure and the possible risk of subclinical kidney damage: a pilot study.

Authors:  Francesca Martino; Gianpaolo Amici; Ilaria Godi; Michele Baretta; Caterina Biasi; Mariarosa Carta; Valentina Corradi; Massimo De Cal; MaÍra Knust; Claudia Tamayod; Alessia Varotto; Giuseppe Iannucci; Davide Giavarina; Sergio Savastano; Claudio Ronco
Journal:  Int Urol Nephrol       Date:  2021-01-13       Impact factor: 2.370

Review 7.  Heart-kidney crosstalk and role of humoral signaling in critical illness.

Authors:  Grazia Virzì; Sonya Day; Massimo de Cal; Giorgio Vescovo; Claudio Ronco
Journal:  Crit Care       Date:  2014-01-06       Impact factor: 9.097

Review 8.  Acute kidney injury in the critically ill: an updated review on pathophysiology and management.

Authors:  Peter Pickkers; Michael Darmon; Eric Hoste; Michael Joannidis; Matthieu Legrand; Marlies Ostermann; John R Prowle; Antoine Schneider; Miet Schetz
Journal:  Intensive Care Med       Date:  2021-07-02       Impact factor: 17.440

9.  Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement.

Authors:  J L Pouchelon; C E Atkins; C Bussadori; M A Oyama; S L Vaden; J D Bonagura; V Chetboul; L D Cowgill; J Elliot; T Francey; G F Grauer; V Luis Fuentes; N Sydney Moise; D J Polzin; A M Van Dongen; N Van Israël
Journal:  J Small Anim Pract       Date:  2015-09       Impact factor: 1.522

10.  Cardiorenal syndrome type 5: in vitro cytotoxicity effects on renal tubular cells and inflammatory profile.

Authors:  Alessandra Brocca; Grazia Maria Virzì; Chiara Pasqualin; Silvia Pastori; Stefano Marcante; Massimo de Cal; Claudio Ronco
Journal:  Anal Cell Pathol (Amst)       Date:  2015-07-22       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.